These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 932552)

  • 1. The Diethylstilbestrol (DES) exposed female in Maine. A discussion with suggestions regarding identification and management applicable to our state.
    Zerner J; Wilkis JL; Fenn ME
    J Maine Med Assoc; 1976 Jun; 67(6):163-5. PubMed ID: 932552
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Prenatal exposure to stilboestrol.
    Med J Aust; 1975 Mar; 1(12):373-4. PubMed ID: 1143126
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Med Assoc State Ala; 1977 Mar; 46(9):39-41. PubMed ID: 845523
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
    Ng AB; Reagan JW; Nadji M; Greening S
    J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The stilbestrol--adenosis--carcinoma--syndrome. A review].
    Ulfelder H
    Geburtshilfe Frauenheilkd; 1975 May; 35(5):329-33. PubMed ID: 1150064
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Vaginal adenocarcinomas and maternal oestrogen ingestion.
    Lancet; 1974 Feb; 1(7851):250-1. PubMed ID: 4130253
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
    Fetherston WC; Meyers A; Speckhard ME
    Wis Med J; 1972 Feb; 71(2):87-93. PubMed ID: 5060564
    [No Abstract]   [Full Text] [Related]  

  • 10. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Trans Pac Coast Obstet Gynecol Soc; 1972; 40():15-29. PubMed ID: 4668177
    [No Abstract]   [Full Text] [Related]  

  • 11. Stilbestrol, adenosis, and adenocarcinoma.
    Ulfelder H
    Am J Obstet Gynecol; 1973 Nov; 117(6):794-800. PubMed ID: 4745178
    [No Abstract]   [Full Text] [Related]  

  • 12. Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero.
    Kurman RJ
    West J Med; 1979 Dec; 131(6):526-32. PubMed ID: 545869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
    Sperling MA
    West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification, examination, and management of diethylstilbestrol-exposed offspring.
    Noller KL; Decker DG; Fish CR; Gaffey TA
    Clin Obstet Gynecol; 1976 Sep; 19(3):699-705. PubMed ID: 954256
    [No Abstract]   [Full Text] [Related]  

  • 15. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
    Scully RE; Robboy SJ; Herbst AL
    Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaginal adenocarcinoma in young women.
    Lancet; 1971 May; 1(7709):1111-2. PubMed ID: 4102630
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vaginal adenocarcinoma as a late result of treatment of threatened abortion with diethylstilbestrol].
    Presl J
    Cesk Gynekol; 1973 Jul; 38(6):473-4. PubMed ID: 4731614
    [No Abstract]   [Full Text] [Related]  

  • 20. Microglandular hyperplasia in vaginal adenosis associated with oral contraceptives and prenatal diethylstilbestrol exposure.
    Robboy SJ; Welch WR
    Obstet Gynecol; 1977 Apr; 49(4):430-4. PubMed ID: 857207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.